PER
Click for more information
4.71% 8.1¢ percheron therapeutics limited

Ann: ANP Submits US Orphan Drug application for ATL1102 in DMD, page-60

  1. MrLearner
    702 Posts.
    lightbulb Created with Sketch. 196
    clock Created with Sketch.
    24/08/20
    16:44
    Post #: 46775229
    Have to agree with you on this point Andy.

    I have positions in MSB and IMU. Their management teams are excellent and their CEO's are superb with both experts at the science behind their products. Both are also extremely articulate. MSB's CEO was brilliant in a recent ODAC meeting to get a 9-1 approval for Remestemcell-L
    ANP Price at posting: 9.8¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 6  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

LRV Larvotto identifies new exploration target at NSW's Hillgrove, boosting shares by nearly 20%
right-arrow Created with Sketch.
NEWS Wealth Within weighs in on shock 4% inflation read – and stocks that could survive the gloom
right-arrow Created with Sketch.
CMX ChemX Materials kicks off first stage works at WA high purity alumina pilot
right-arrow Created with Sketch.
SVL Silver Mines models five new calderas close to 396Moz Bowdens deposit
right-arrow Created with Sketch.
AVA Ava Risk Group expands US presence with A$0.7M Substation Deal
right-arrow Created with Sketch.
NEWS Week 26 Wrap: Cerberus of inflation barks – rents, electricity & fuel – and world watches two elders bicker
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.1¢ 		Change
-0.004(4.71%) 		Mkt cap ! $76.63M
Open High Low Value Volume
8.1¢ 8.1¢ 8.1¢ $13.33K 164.6K

Buyers (Bids)

No. Vol. Price($)
3 143000 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.1¢ 39386 1
View Market Depth
Last trade - 10.15am 01/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.